These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

208 related items for PubMed ID: 7695981

  • 1. Is carboplatin and oral etoposide an effective and feasible regimen in patients with small cell lung cancer?
    Pfeiffer P, Sørensen P, Rose C.
    Eur J Cancer; 1995; 31A(1):64-9. PubMed ID: 7695981
    [Abstract] [Full Text] [Related]

  • 2. Paclitaxel, carboplatin, and extended-schedule etoposide in the treatment of small-cell lung cancer: comparison of sequential phase II trials using different dose-intensities.
    Hainsworth JD, Gray JR, Stroup SL, Kalman LA, Patten JE, Hopkins LG, Thomas M, Greco FA.
    J Clin Oncol; 1997 Dec; 15(12):3464-70. PubMed ID: 9396399
    [Abstract] [Full Text] [Related]

  • 3. Dose-intense therapy with etoposide, ifosfamide, cisplatin, and epirubicin (VIP-E) in 100 consecutive patients with limited- and extensive-disease small-cell lung cancer.
    Fetscher S, Brugger W, Engelhardt R, Kanz L, Hasse J, Frommhold H, Wenger M, Lange W, Mertelsmann R.
    Ann Oncol; 1997 Jan; 8(1):49-56. PubMed ID: 9093707
    [Abstract] [Full Text] [Related]

  • 4. Randomized comparison of early versus late hyperfractionated thoracic irradiation concurrently with chemotherapy in limited disease small-cell lung cancer: a randomized phase II study of the Hellenic Cooperative Oncology Group (HeCOG).
    Skarlos DV, Samantas E, Briassoulis E, Panoussaki E, Pavlidis N, Kalofonos HP, Kardamakis D, Tsiakopoulos E, Kosmidis P, Tsavdaridis D, Tzitzikas J, Tsekeris P, Kouvatseas G, Zamboglou N, Fountzilas G.
    Ann Oncol; 2001 Sep; 12(9):1231-8. PubMed ID: 11697833
    [Abstract] [Full Text] [Related]

  • 5. Carboplatin, etoposide, and ifosfamide as intensive chemotherapy for small-cell lung cancer.
    Smith IE, Perren TJ, Ashley SA, Woodiwiss J, Forgeson GV, Yarnold JR, Ford HT.
    J Clin Oncol; 1990 May; 8(5):899-905. PubMed ID: 2159056
    [Abstract] [Full Text] [Related]

  • 6. Standard- and high-dose etoposide, ifosfamide, carboplatin, and epirubicin in 100 patients with small-cell lung cancer: a mature follow-up report.
    Fetscher S, Brugger W, Engelhardt R, Kanz L, Hasse J, Frommhold H, Lange W, Mertelsmann R.
    Ann Oncol; 1999 May; 10(5):561-7. PubMed ID: 10416006
    [Abstract] [Full Text] [Related]

  • 7. Paclitaxel, carboplatin, and oral etoposide in the treatment of small cell lung cancer.
    Greco FA, Hainsworth JD.
    Semin Oncol; 1996 Dec; 23(6 Suppl 16):7-10. PubMed ID: 9007113
    [Abstract] [Full Text] [Related]

  • 8. Oral etoposide and carboplatin. Effective therapy for elderly patients with small cell lung cancer.
    Evans WK, Radwi A, Tomiak E, Logan DM, Martins H, Stewart DJ, Goss G, Maroun JA, Dahrouge S.
    Am J Clin Oncol; 1995 Apr; 18(2):149-55. PubMed ID: 7534977
    [Abstract] [Full Text] [Related]

  • 9. Concurrent cisplatin, prolonged oral etoposide, and vincristine plus chest and brain irradiation for limited small cell lung cancer: a phase II study of the Southwest Oncology Group (SWOG-9229).
    Thomas CR, Giroux DJ, Stelzer KJ, Craig JB, Laufman LR, Taylor SA, Goodwin JW, Crowley JJ, Livingston RB.
    Int J Radiat Oncol Biol Phys; 1998 Mar 15; 40(5):1039-47. PubMed ID: 9539558
    [Abstract] [Full Text] [Related]

  • 10. Combination chemotherapy with low doses of weekly Carboplatin and oral Etoposide in poor risk small cell lung cancer.
    Samantas E, Skarlos DV, Pectasides D, Nicolaides P, Kalofonos H, Mylonakis N, Vardoulakis Th, Kosmidis P, Pavlidis N, Fountzilas G.
    Lung Cancer; 1999 Feb 15; 23(2):159-68. PubMed ID: 10217620
    [Abstract] [Full Text] [Related]

  • 11. Randomized comparison of etoposide-cisplatin vs. etoposide-carboplatin and irradiation in small-cell lung cancer. A Hellenic Co-operative Oncology Group study.
    Skarlos DV, Samantas E, Kosmidis P, Fountzilas G, Angelidou M, Palamidas P, Mylonakis N, Provata A, Papadakis E, Klouvas G.
    Ann Oncol; 1994 Sep 15; 5(7):601-7. PubMed ID: 7993835
    [Abstract] [Full Text] [Related]

  • 12. Paclitaxel, carboplatin, and extended schedule etoposide in the treatment of small cell lung carcinoma.
    Hainsworth JD, Stroup SL, Greco FA.
    Cancer; 1996 Jun 15; 77(12):2458-63. PubMed ID: 8640693
    [Abstract] [Full Text] [Related]

  • 13. A randomized, controlled phase III study of cyclophosphamide, doxorubicin, and vincristine with etoposide (CAV-E) or teniposide (CAV-T), followed by recombinant interferon-alpha maintenance therapy or observation, in small cell lung carcinoma patients with complete responses.
    Tummarello D, Mari D, Graziano F, Isidori P, Cetto G, Pasini F, Santo A, Cellerino R.
    Cancer; 1997 Dec 15; 80(12):2222-9. PubMed ID: 9404698
    [Abstract] [Full Text] [Related]

  • 14. A phase I study of dose-dense topotecan given upfront to standard therapy in patients with small cell lung cancer.
    Garst J, Herndon JE, Shafman T, Campagna L, Blackwell S, Padilla K, Bjurstrom T, Andrews C, Maravich-May D, Anderson E, Crawford J.
    Clin Drug Investig; 2006 Dec 15; 26(5):257-66. PubMed ID: 17163259
    [Abstract] [Full Text] [Related]

  • 15. Combination chemotherapy with cisplatin and etoposide associated with radiotherapy in the treatment of small-cell lung cancer.
    Figoli F, Veronesi A, Trovo MG, Errante D, Della Valentina M, Zagonel V, Talamini R, Magri MD, Monfardini S.
    Cancer Chemother Pharmacol; 1989 Dec 15; 24(6):381-5. PubMed ID: 2551521
    [Abstract] [Full Text] [Related]

  • 16. Carboplatin (Paraplatin; JM8) and etoposide (VP-16) as first-line combination therapy for small-cell lung cancer.
    Smith IE, Evans BD, Gore ME, Vincent MD, Repetto L, Yarnold JR, Ford HT.
    J Clin Oncol; 1987 Feb 15; 5(2):185-9. PubMed ID: 3027268
    [Abstract] [Full Text] [Related]

  • 17. Efficacy and safety of ifosfamide in combination with carboplatin and etoposide in small cell lung cancer.
    Lee HS, Lee YG, Koo DH, Oh S, Nam H, Song JU, Lim SY, Lim SY, Lee SS.
    Cancer Chemother Pharmacol; 2015 Nov 15; 76(5):933-7. PubMed ID: 26374553
    [Abstract] [Full Text] [Related]

  • 18. Dose escalation study of carboplatin with fixed-dose etoposide plus granulocyte-colony stimulating factor in patients with small cell lung carcinoma. A study of the Lung Cancer Study Group of West Japan.
    Katakami N, Takada M, Negoro S, Ota K, Fujita J, Furuse K, Ariyoshi Y, Ikegami H, Fukuoka M.
    Cancer; 1996 Jan 01; 77(1):63-70. PubMed ID: 8630941
    [Abstract] [Full Text] [Related]

  • 19. Pilot study of cyclophosphamide-doxorubicin-vincristine-cisplatin-etoposide hybrid chemotherapy in small cell lung cancer.
    Ohnoshi T, Hiraki S, Ueoka H, Kiura K, Kamei H, Horiguchi T, Kodani T, Maeda T, Tabata M, Shibayama T.
    Cancer; 1993 Sep 01; 72(5):1597-601. PubMed ID: 8394202
    [Abstract] [Full Text] [Related]

  • 20. Combination chemotherapy with carboplatin, etoposide, and vincristine as first-line treatment in small-cell lung cancer.
    Gatzemeier U, Hossfeld DK, Neuhauss R, Reck M, Achterrath W, Lenaz L.
    J Clin Oncol; 1992 May 01; 10(5):818-23. PubMed ID: 1314891
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.